We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

115 hedge funds and large institutions have $757M invested in Avidity Biosciences in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

173,100% more call options, than puts

Call options by funds: $3.46M | Put options by funds: $2K

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

132% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 19

12% more funds holding

Funds holding: 103 → 115 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.12% less ownership

Funds ownership: 106.91% → 104.79% (-2.1%)

30% less capital invested

Capital invested by funds: $1.09B → $757M (-$328M)

Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
44
Reduced
19
Closed
5
Calls
$3.46M
Puts
$2K
Net Calls
+$3.46M
Net Calls Change
+$747K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$33.7M
2
BlackRock
BlackRock
New York
+$9.9M
3
Artisan Partners
Artisan Partners
Wisconsin
+$5.85M
4
State Street
State Street
Massachusetts
+$2.91M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
AWA
Aaron Wealth Advisors
Illinois
-$56.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.52M
3
ACM
Altium Capital Management
New York
-$1.38M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1M
5
ACM
Alethea Capital Management
Washington
-$811K
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$270K +$56.2K +3,776 +26%
Los Angeles Capital Management
77
Los Angeles Capital Management
California
$257K -$546K -36,679 -67%
Susquehanna International Group
78
Susquehanna International Group
Pennsylvania
$246K -$50.7K -3,406 -17%
VF
79
Virtu Financial
New York
$238K +$244K +16,377 New
DTL
80
Dynamic Technology Lab
Singapore
$235K +$241K +16,199 New
Mirae Asset Global Investments
81
Mirae Asset Global Investments
South Korea
$175K +$180K +12,086 New
DY
82
Dowling & Yahnke
California
$164K – – –
TRCT
83
Tower Research Capital (TRC)
New York
$160K +$143K +9,620 +691%
Ensign Peak Advisors
84
Ensign Peak Advisors
Utah
$157K – – –
CIC
85
Cornercap Investment Counsel
Georgia
$156K +$159K +10,703 New
EAM
86
Erste Asset Management
Austria
$156K – – –
TYCC
87
Texas Yale Capital Corp
Florida
$145K – – –
VEA
88
Virtus ETF Advisers
New York
$128K +$37.1K +2,495 +40%
AB
89
Amalgamated Bank
New York
$90K +$20.5K +1,381 +29%
PFS
90
Prospera Financial Services
Texas
$88K -$1.26K -85 -1%
Zurich Cantonal Bank
91
Zurich Cantonal Bank
Switzerland
$78K -$1.49K -100 -2%
AIP
92
Ameritas Investment Partners
Nebraska
$53K +$11.6K +780 +27%
AA
93
Ancora Advisors
Ohio
$44K +$44.6K +3,000 New
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
$43.2K +$11.4K +764 +35%
QT
95
Quantbot Technologies
New York
$30K +$26.8K +1,800 +600%
Canada Life
96
Canada Life
Manitoba, Canada
$28K – – –
Allspring Global Investments
97
Allspring Global Investments
North Carolina
$23K – – –
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$5K -$36.3K -2,438 -87%
BHWM
99
Beaird Harris Wealth Management
Texas
$3K – – –
CAPTRUST Financial Advisors
100
CAPTRUST Financial Advisors
North Carolina
$3K – – –
1 2 3
4
5

RNAM Hedge Fund Activity: Q2 2022 in Review

115 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q2 2022, worth a combined $757M — down 30% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RNAM positions and 5 closed out — a net gain of 14 holders — while 44 added to existing stakes and 19 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $33.7M. The largest seller was Aaron Wealth Advisors, cutting an estimated $56.1M.

  • 115 institutional investors held Avidity Biosciences (RNAM) as of Q2 2022, up from 103 in Q1 2022.
  • Funds reported $757M of Avidity Biosciences stock for Q2 2022, down 30% quarter-over-quarter.
  • 19 funds opened new Avidity Biosciences positions in Q2 2022 and 5 closed out, a net change of +14 holders.
  • The largest Avidity Biosciences buyer in Q2 2022 was Cowen and Company, an estimated $33.7M added.
  • The largest Avidity Biosciences seller in Q2 2022 was Aaron Wealth Advisors, an estimated $56.1M sold.

Based on aggregated 13F filings for Q2 2022.